comparemela.com

Latest Breaking News On - கொடுக்கப்பட்டது இமேஜிங் - Page 5 : comparemela.com

Israel s newest tycoon has his work cut out for him - Business

Follow Apr. 12, 2021 Tzahi Nahmias was already very rich when he acquired Discount Investment Corp. a few months ago. But he doesn’t play the role of tycoon: He doesn’t work around the clock and his property company, Mega Or, occupies modest offices in Moshav Shilat with a discount supermarket on the ground level. He and his family live in the same moshav. “If you know how to make the right decisions and have a team you can rely on, you don’t need to be working 24/7,” he once told an associate. But those who have done business with Nahmias say there’s a difference between his public and private personas. “At Mega Or, which is publicly traded, Nahmias conducts himself modestly and efficiently, but in his private life he lives well (for example, he owns several luxury cars). Even when he’s taking time off, he spends a lot of time thinking about how to build his business. So far, he’s been successful at it,” says someone who asked not to be identified.

Biophotonics Market: Global Share, Size, Trends and Growth Analysis Forecast to 2021-2026

Biophotonics Market: Global Share, Size, Trends and Growth Analysis Forecast to 2021-2026
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

Kadimastem hopes to turn corner with new top management

Kadimastem hopes to turn corner with new management The Israeli stem cell technology company has named Asaf Shiloni CEO, after three new expert directors joined its board. Israeli stem cell technology company Kadimastem (TASE: KDST) has had a chequered history, with frequent going concern warnings on its financials, a downward drifting share price from its 2016 peak, and the departure last year of founder and CEO Yossi Ben-Yosef. The company now hopes to have turned a corner with the appointment of a new and experienced CEO and new directors. Kadimastem has named Asaf Shiloni, who was Vice President of Sales and Business Development at California-based PeproTech Inc., as CEO. PeproTech is the leading manufacturer of GMP Cytokines, vital components in all stem cell and cell therapy clinical trials. Kadimastem s announcement states that at PeproTech Shiloni established collaborations and joint ventures with top US stem cell companies and leading research labs worldwide, and also led

Kadimastem Announces Executive Management Changes

Kadimastem Announces Executive Management Changes USA - English Accomplished US Life Science and Biotech Executive Asaf Shiloni Named New CEO Company Appoints Biotech Industry Leaders Ronen Twito, CPA as Co-Chairperson and Doron Birger and Ron Mayron to the Company s Board of Directors News provided by Share this article NESS ZIONA, Israel, Feb. 1, 2021 /PRNewswire/   Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, announces the appointment of Asaf Shiloni as CEO. This follows a series of executive management appointments in the last month including Mr. Ronen Twito, CPA, as Co-Chairperson of Kadimastem s Board of Directors, and new expert Board members, Mr. Doron Birger and Mr. Ron Mayron. All are highly accomplished biotechnology industry experts, dedicated to working in concert to secure a bright future for the company.

Medical Automation Market 2021 Key players, Global Trend, Industry Size, Share, Price and Opportunities Forecast to 2026

Medical Automation Market 2021 Key players, Global Trend, Industry Size, Share, Price and Opportunities Forecast to 2026
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.